Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway

International Journal of Oncology

Volumn 38, Issue 3, 2011, Pages 603-611

  Teiten, Marie Hélène ^a   Gaascht, François ^a   Cronauer, Marcus ^b   Henry, Estelle ^a   Dicato, Mario ^a   Diederich, Marc ^a  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Cell cycle; Cell death; Curcumin; Proliferation; Prostate cancer; Wingless signaling

Indexed keywords

ANDROGEN; BETA CATENIN; CURCUMIN; CYCLIN D1; PROTEIN P300; WNT1 PROTEIN;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL PROLIFERATION; CELL VIABILITY; CHEMOPROPHYLAXIS; CURCUMA LONGA; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION;

ANDROGENS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 79952032733     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.905     Document Type: Article

References (54)

1. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
2. Verras M and Sun Z: Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett 237: 22-32, 2006.
3. Yardy GW and Brewster SF: Wnt signalling and prostate cancer. Prostate Cancer Prostatic Dis 8: 119-126, 2005. (Pubitemid 43118074)
4. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480, 2006.
5. Camilli TC and Weeraratna AT: Striking the target in Wnt-y conditions: intervening in Wnt signaling during cancer progression. Biochem Pharmacol (In press).
6. Hurlstone A and Clevers H: T-cell factors: turn-ons and turnoffs. EMBO J 21: 2303-2311, 2002.
7. Barker N and Clevers H: Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 5: 997-1014, 2006. (Pubitemid 44835127)
8. Janssens N, Janicot M and Perera T: The Wnt-dependent signaling pathways as target in oncology drug discovery. Invest New Drugs 24: 263-280, 2006.
9. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
10. Kundu JK, Choi KY and Surh YJ: beta-catenin-mediated signaling: a novel molecular target for chemoprevention with anti-inflammatory substances. Biochim Biophys Acta 1765: 14-24, 2006.
11. Lu W, Tinsley HN, Keeton A, Qu Z, Piazza GA and Li Y: Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. Eur J Pharmacol 602: 8-14, 2009.
12. Aggarwal BB, Kumar A and Bharti AC: Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23: 363-398, 2003. (Pubitemid 36361976)
13. Teiten MH, Eifes S, Dicato M and Diederich M: Curcumin - the paradigm of multi-target natural compound with applications in cancer prevention and treatment. Toxins 2: 128-162, 2010.
14. Prasad CP, Rath G, Mathur S, Bhatnagar D and Ralhan R: Potent growth suppressive activity of curcumin in human breast cancer cells: modulation of Wnt/beta-catenin signaling. Chem Biol Interact 181: 263-271, 2009.
15. Ryu MJ, Cho M, Song JY, et al: Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun 377: 1304-1308, 2008.
16. Park CH, Hahm ER, Park S, Kim HK and Yang CH: The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling. FEBS Lett 579: 2965-2971, 2005. (Pubitemid 40725275)
17. Jaiswal AS, Marlow BP, Gupta N and Narayan S: Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21: 8414-8427, 2002. (Pubitemid 36061200)
18. Teiten MH, Gaascht F, Eifes S, Dicato M and Diederich M: Chemopreventive potential of curcumin in prostate cancer. Genes Nutr 5: 61-74, 2010.
19. Bostwick DG: Progression of prostatic intraepithelial neoplasia to early invasive adenocarcinoma. Eur Urol 30: 145-152, 1996.
20. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2[-Delta Delta C(T)] method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
21. Schreiber E, Matthias P, Muller MM and Schaffner W: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17: 6419, 1989.
22. Gray JW and Coffino P: Cell cycle analysis by flow cytometry. Methods Enzymol 58: 233-248, 1979.
23. Mizushima N and Yoshimori T: How to interpret LC3 immunoblotting. Autophagy 3: 542-545, 2007. (Pubitemid 350060049)
24. Cronauer MV, Schulz WA, Ackermann R and Burchardt M: Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines. Int J Oncol 26: 1033-1040, 2005.
25. Robinson DR, Zylstra CR and Williams BO: Wnt signaling and prostate cancer. Curr Drug Targets 9: 571-580, 2008.
26. Kakarala M, Brenner DE, Korkaya H, et al: Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat (In press).
27. Narayan S: Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting betacatenin-mediated transactivation and cell-cell adhesion pathways. J Mol Histol 35: 301-307, 2004.
28. Reuter S, Eifes S, Dicato M, Aggarwal BB and Diederich M: Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76: 1340-1351, 2008.
29. Dorai T, Gehani N and Katz A: Therapeutic potential of curcumin in human prostate cancer-I. curcumin induces apoptosis in both androgen-dependent and androgen-independent prostate cancer cells. Prostate Cancer Prostatic Dis 3: 84-93, 2000. (Pubitemid 30665213)
30. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P and Aggarwal BB: Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20: 7597-7609, 2001. (Pubitemid 33111860)
31. Lin SS, Huang HP, Yang JS, et al: DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation of caspase cascade- and mitochondrial-dependent pathway. Cancer Lett 272: 77-90, 2008.
32. Song G, Mao YB, Cai QF, Yao LM, Ouyang GL and Bao SD: Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz J Med Biol Res 38: 1791-1798, 2005. (Pubitemid 43078608)
33. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB and Kondo Y: Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 72: 29-39, 2007.
34. Shinojima N, Yokoyama T, Kondo Y and Kondo S: Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 3: 635-637, 2007. (Pubitemid 350060068)
35. Jia YL, Li J, Qin ZH and Liang ZQ: Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res 11: 918-928, 2009.
36. Pattingre S, Tassa A, Qu X, et al: Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927-939, 2005. (Pubitemid 41345209)
37. Maiuri MC, Le Toumelin G, Criollo A, et al: Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 26: 2527-2539, 2007. (Pubitemid 46788315)
38. O'Sullivan-Coyne G, O'Sullivan GC, O'Donovan TR, Piwocka K and McKenna SL: Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer 101: 1585-1595, 2009.
39. Moretti L, Yang ES, Kim KW and Lu B: Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist Updat 10: 135-143, 2007. (Pubitemid 47454724)
40. Choi BH, Kim CG, Bae YS, Lim Y, Lee YH and Shin SY: p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression. Cancer Res 68: 1369-1377, 2008. (Pubitemid 351346844)
41. Hour TC, Chen J, Huang CY, Guan JY, Lu SH and Pu YS: Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate 51: 211-218, 2002. (Pubitemid 34492642)
42. Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S and Sethi G: Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol 73: 1024-1032, 2007. (Pubitemid 46283583)
43. Hanif R, Qiao L, Shiff SJ and Rigas B: Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J Lab Clin Med 130: 576-584, 1997. (Pubitemid 28029226)
44. Sahu RP, Batra S and Srivastava SK: Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer 100: 1425-1433, 2009.
45. Ramachandran C and You W: Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat 54: 269-278, 1999. (Pubitemid 29322350)
46. Park C, Kim GY, Kim GD, Choi BT, Park YM and Choi YH: Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep 15: 1225-1231, 2006.
47. Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999. (Pubitemid 29180374)
48. He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998. (Pubitemid 28425575)
49. Altieri DC: Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3: 46-54, 2003.
50. Sherr CJ: Cancer cell cycles. Science 274: 1672-1677, 1996.
51. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M and Aggarwal BB: Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21: 8852-8861, 2002. (Pubitemid 36132405)
52. Leow P, Tian Q, Ong Z, Yang Z and Ee P: Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/betacatenin antagonists against human osteosarcoma cells. Invest New Drugs (In press).
53. Hecht A, Vleminckx K, Stemmler MP, van Roy F and Kemler R: The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J 19: 1839-1850, 2000.
54. Balasubramanyam K, Varier RA, Altaf M, et al: Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase- dependent chromatin transcription. J Biol Chem 279: 51163-51171, 2004. (Pubitemid 40017859)